Cocrystal Pharma Inc. (NASDAQ:COCP) and Alector Inc. (NASDAQ:ALEC) compete against each other in the Biotechnology sector. We will compare them and contrast their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation.

Earnings & Valuation

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cocrystal Pharma Inc.	N/A	0.00	N/A	0.04	81.05
Alector Inc.	27.68M	49.30	52.25M	-0.65	0.00

Table 1 highlights Cocrystal Pharma Inc. and Alector Inc.’s top-line revenue, earnings per share and valuation.

Profitability

Table 2 provides Cocrystal Pharma Inc. and Alector Inc.’s return on assets, net margins and return on equity.

	Net Margins	Return on Equity	Return on Assets
Cocrystal Pharma Inc.	0.00%	0.4%	0.4%
Alector Inc.	-188.76%	0%	0%

Liquidity

The Current Ratio of Cocrystal Pharma Inc. is 4.4 while its Quick Ratio stands at 4.4. The Current Ratio of rival Alector Inc. is 7.6 and its Quick Ratio is has 7.6. Alector Inc. is better equipped to clear short and long-term obligations than Cocrystal Pharma Inc.

Analyst Ratings

The next table highlights the shown recommendations and ratings for Cocrystal Pharma Inc. and Alector Inc.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
Cocrystal Pharma Inc.	0	0	0	0.00
Alector Inc.	0	0	2	3.00

Alector Inc. on the other hand boasts of a $27 consensus target price and a 36.29% potential upside.

Institutional and Insider Ownership

The shares of both Cocrystal Pharma Inc. and Alector Inc. are owned by institutional investors at 7.2% and 37.4% respectively. 67.67% are Cocrystal Pharma Inc.’s share held by insiders. On the other hand, insiders held about 8.2% of Alector Inc.’s shares.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
Cocrystal Pharma Inc.	12%	6.21%	-8.06%	-16.93%	-23%	-14.44%
Alector Inc.	-3.11%	0%	0%	0%	0%	15.89%

For the past year Cocrystal Pharma Inc. had bearish trend while Alector Inc. had bullish trend.

Summary

Cocrystal Pharma Inc. beats Alector Inc. on 6 of the 11 factors.

Cocrystal Pharma, Inc., a preclinical-stage biopharmaceutical company, focuses on developing antiviral therapeutics for human diseases. The company focuses on developing inhibitors that target viral replication enzymes and viral replication protein. It is developing antiviral therapeutics for human diseases, including hepatitis C virus (HCV), influenza virus, and norovirus. The company also develops targeted in-house chemical libraries consisting of nucleosides, non-nucleoside inhibitors, metal-binding inhibitors, and fragments. It has research collaboration agreement with HitGen, Ltd. and InterX, Inc. to develop small molecule drug candidates against several undisclosed targets. Cocrystal Pharma, Inc. was founded in 2007 and is headquartered in Tucker, Georgia.